Prescription Drug Rebate Reform Act of 2019
- Last Action
- 5/9/2019
CRS Summary
As of 2019-05-09 (00)
Prescription Drug Rebate Reform Act of 2019
This bill requires private health insurance plans to set any coinsurance rate for a covered prescription drug based on the net price of the drug (the price after accounting for rebates and discounts provided by the drug manufacturer) and not the list price (the initial wholesale price set by the drug manufacturer). This requirement applies when a plan holder has an unmet deductible or other coinsurance obligation for prescription drug benefits under the plan.
The bill does not prohibit a plan from requiring a copayment provided that such copayment is not based on the cost of the drug.
Cosponsors (2)
- Mike Braun (R-IN)
- Marsha Blackburn (R-TN)
Subjects
- Health care costs and insurance
- Health care coverage and access
- Inflation and prices
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.